Manufacturer record
Pure & Cure Healthcare Pvt. Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
30 batches manufactured by Pure & Cure Healthcare Pvt. Ltd (Uttarakhand) were declared Not of Standard Quality between September 2019 and September 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: CJO02AAA, Capsules of L-Arginine, Ubidecarenone, Lycopene, Vitamins and Piperine (exp Jul 2027). Drug Testing Laboratory, Madurai-19 (state lab) found it not of standard quality: content- Pyridoxine hydrochloride. Listed in the September 2026 alert.
Records by type
30 records linked to Pure & Cure Healthcare Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
0Banned or prohibited
0Recalled or suspended
30Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
30
NSQ batches since 2019
28
Products affected
Assay
Most common failure
Sep 2026
Latest alert
Flagged batches per year
2019 · 12021 · 52022 · 72023 · 12024 · 52025 · 42026 · 7
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Capsules of L-Arginine, Ubidecarenone, Lycopene, Vitamins and Piperine | Batch CJO02AAAMfg Nov 2025 · Exp Jul 2027 | content- Pyridoxine hydrochlorideOther | Drug Testing Laboratory, Madurai-19State lab | Sep 2026 |
| Paracetamol and Tramadol Hydrochloride Tablets I.P | Batch COS03AHAMfg Jun 2025 · Exp May 2027 | Assay for Tramadol HydrochlorideAssay | RDTL, Hubli, KarnatakaState lab | Aug 2026 |
| Pantoprazole Tablets IP | Batch AGW01AKAMfg Sep 2025 · Exp Aug 2027 | The sample does not conform to IP standards. It fails the test Dissolution.Dissolution | DTL, KonniState lab | Jul 2026 |
| Levocetirizine & Montelukast Sodium Dispersible tablets | Batch ABC04ABAMfg Dec 2025 · Exp Nov 2027 | The sample does not conform to Label claim with respect to content of Montelukast in Montelukast sodium)Labelling | Drugs Testing Laboratory, Madurai-19State lab | Jul 2026 |
| Phenazone & Lidocaine Hydrochloride Ear Drops -5ml | Batch AOT01ACBMfg Jan 2026 · Exp Dec 2027 | ContentOther | DTL, Chennai-25State lab | Jun 2026 |
| Flunarizine Tablets IP 10mg | Batch AUJ01AQAMfg Aug 2025 · Exp Jul 2028 | Sample fails the Descriptive part for tablets as per IP.Other | DTL ThiruvananthapuramState lab | Feb 2026 |
| Flunarizine Tablets IP 10mg | Batch AUJ01AQAMfg Aug 2025 · Exp Jul 2028 | sample fails the test 'Descriptive Part' for tablets as per IP, as specified in the laboratory protocol.Other | DTL ThiruvananthapuramState lab | Jan 2026 |
| Albendazole Tablets IP 400 mg (ALBISTI ? 400) | Batch PI28AH05Mfg Jul 2023 · Exp Dec 2025 | The Sample does not conform to standard in respect of the test for DissolutionDissolution | State Drugs Testing Laboratory, Agartala, TripuraState lab | May 2025 |
| Progaba Gel (Lidocaine Hydrochloride & Gabapentin Gel) | Batch PSWAB66Mfg Jun 2024 · Exp Nov 2025 | Sample does not conform to Label claim with respect to the content of GabapentinLabelling | DTL MaduraiState lab | Apr 2025 |
| Ondansentron Tablets IP 4mg | Batch PS39AB06Mfg Jun 2023 · Exp May 2025 | The sample does not comply with IP requirements for Dissolution testDissolution | CDTL MumbaiCDSCO lab | Apr 2025 |
| Lidocaine Hydrochloride and Gabapentin Gel (Gabaneuron Gel) | Batch PWBBO7Mfg Jun 2024 · Exp Nov 2025 | Sample does not conform to lebel claim with respect to the content of GabapentinOther | DTL MaduraiState lab | Apr 2025 |
| Octenidine Dihydrochlordie Gel | Batch PPKAC84Mfg May 2023 · Exp Apr 2026 | Sample does not conform to label claim with respect to the content of Octenidine Dihydrochloride.Labelling | DTL MaduraiState lab | Dec 2024 |
| Montair LC Kid (Montelukast Sodium & Levocetirizne Hydrochloride Dispersible Tablets) | Batch AFB23W73Mfg Sep 2023 · Exp Aug 2025 | Uniformity of Dispersion & Assay of Montelukast SodiumAssay | CDL KolkataCDSCO lab | Aug 2024 |
| Calcium And Vitamin D3 Tablets IP Shelcal 500 (Shelcal) | Batch GDXD0581Mfg Aug 2023 · Exp Jul 2025 | Description, Identification of Vitamin D3, Dissolution of Calcium and Assay of Calcium & Vitamin D3Assay | CDL KolkataCDSCO lab | Aug 2024 |
| Domperidone and Naproxen Sodium Tablets (Naxdom 500) | Batch FHA0966Mfg Dec 2023 · Exp Nov 2026 | Not applicableOther | Not applicableState lab | Apr 2024 |
| Trypsin, Bromelain & Rutoside Trihydrate Tablets | Batch PF8CC12Mfg Aug 2023 · Exp Jul 2025 | Assay of 'Trypsin'Assay | CDL KolkataCDSCO lab | Jan 2024 |
| Telmisartan and Chlorthalidone Tablets | Batch PF8C006Mfg Sep 2022 · Exp Aug 2024 | Dissolution of ChlorthalidoneDissolution | CDL KolkataCDSCO lab | Aug 2023 |
| SHELCAL�-500 (Calcium And Vitamin D3 Tablets I.P.) | Batch 8LV2H077Mfg Jun 2021 · Exp May 2023 | Identification of Vitamin D3, Dissolution (Calcium) and Assay of Elemental Calcium & Vitamin D3Assay | RDTL GuwahatiState lab | Nov 2022 |
| Alprasafe - 0.5 (Alprazolam Tablets I.P. 0.5 mg) | Batch PE25AD01Mfg Oct 2021 · Exp Mar 2024 | Dissolution & Uniformity of ContentDissolution | CDL KolkataCDSCO lab | Nov 2022 |
| L - Methylfolate Tablets | Batch PF8CY03Mfg Apr 2022 · Exp Mar 2024 | DescriptionDescription | CDL KolkataCDSCO lab | Oct 2022 |
| DIVALPROEX SODIUM TABLETS IP 500 mg | Batch PF8AO19Mfg Jul 2021 · Exp Jun 2023 | Dissolution (Buffer stage)Dissolution | CDTL HyderabadCDSCO lab | Sep 2022 |
| Clopidogrel and Aspirin Tablets I.P. | Batch PR14AD14Mfg Feb 2022 · Exp Jan 2024 | Free Salicylic Acid (Related Substances for Aspirin)Related substances | CDL KolkataCDSCO lab | Sep 2022 |
| Acebrophylline Capsules 100 mg | Batch PF8AA04Mfg Nov 2020 · Exp Oct 2022 | Water ContentWater content | CDL KolkataCDSCO lab | May 2022 |
| Calcium with Vitamin D3 Tablets IP (SHELCAL-500 TABLETS) | Batch GAVB0034Mfg Jan 2021 · Exp Dec 2022 | Assay of Vitamin D3 and uniformity of weightAssay | RDTL ChandigarhState lab | Feb 2022 |
| Rabeprazole Injection IP 20 mg | Batch PE3AA11Mfg Oct 2019 · Exp Sep 2021 | Clarity of Solution & Particulate MatterParticulate matter | CDL KolkataCDSCO lab | Oct 2021 |
| Rabeprazole Injection IP, 20 mg WFI | Batch PE3AA14Mfg Jun 2020 · Exp May 2022 | Description, Clarity of Solution, Particulate Matter, pH, Related Substances & AssayAssay | CDL KolkataCDSCO lab | Sep 2021 |
| Doxylamine Succinate & Pyridoxine Hydrochloride Tablets | Batch PF8BI02Mfg Mar 2020 · Exp Feb 2022 | Disintegration & Assay of Doxylamine SuccinateAssay | CDL KolkataCDSCO lab | Sep 2021 |
| Ambilon 50 (Amphotericin B Liposome Injection 50 mg) | Batch T1113A0Mfg Jan 2020 · Exp Dec 2023 | AssayAssay | CDL KolkataCDSCO lab | Sep 2021 |
| Doxylamine Succinate & Pyridoxine Hydrochloride Tablets | Batch PF8B101Mfg Aug 2019 · Exp Jul 2021 | Disintegration TimeDisintegration | CDTL MumbaiCDSCO lab | Feb 2021 |
| Okacet-L (Levocetirizine Tablets I.P. 5 mg) | Batch AFB8D36Mfg Sep 2018 · Exp Aug 2020 | Related SubstancesRelated substances | CDL KolkataCDSCO lab | Sep 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.